Krystal Biotech, Inc.’s KRYS share price has dipped by 12.19%, which has investors questioning if this is right time to buy.

PITTSBURGH, May 06, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company”) (NASDAQ: KRYS) today reported financial results for the first quarter ending March 31, 2025 and provided a business ...

Even humans in ancient times would wash their bodies and skin with water with some frequency,” Dr. Jennifer Shastry, a ...

It is a hunting dog, work partner, and family friend all in one. With its shiny golden coat and friendly expression, it ranks ...

MSM is an anti-inflammatory dietary supplement sometimes used to reduce pain, improve skin health, relieve allergies, and ...

A Labour MP has been given a formal reminder of conduct after sharing a social media post accusing Sir Keir Starmer of taking ...

Timber's lead candidate TMB-001 for rare skin disease congenital ichthyosis failed to meet its efficacy objectives across the board in the ASCEND trial and will not support a planned regulatory ...

Another possibility is ichthyosis vulgaris, an inherited condition where the skin barrier doesn’t function properly, leading to scaly skin. Regardless of what is actually happening to Zakher’s ...

Krystal Biotech KRYS reported first-quarter 2025 earnings per share (EPS) of $1.20, which missed the Zacks Consensus Estimate ...

In April 2025, Novartis Pharmaceuticals announced study is to establish the efficacy, safety, and tolerability of ...

Top solutions for prickly heat revealed - Discover the most effective treatments for sweat rash and how they can help alleviate discomfort.